The following reagents and antibodies were used for biological experiments: anisomycin (NeoCorp, Weilheim, Germany);
annexin-V-FITC (BD Bioscience, San Jose, CA, USA); docetaxel (Pharmacy of the University Hospital Hamburg-Eppendorf, Hamburg, Germany);
SP600125 (JNK1/2 inhibitor) and
SB203580 (p38 inhibitor) (LC Laboratories, Woburn, MA, USA);
PD98059 (MEK inhibitor) (Merck Chemicals GmbH, Darmstadt, Germany); PhosphoSTOP™
EASYpacks phosphotase inhibitors cocktail and cOmplete™
EASYpacks protease inhibitors cocktail (Roche, Mannheim, Germany); propidium iodide (PI), MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) (Sigma, Taufkirchen, Germany);
RNase (Carl Roth, Karlsruhe, Germany);
tariquidar (p-glycoprotein inhibitor) (MedChemExpress, Monmouth Junction, NJ, USA); primary and secondary antibodies used are listed in
Table 2.
Dyshlovoy S.A., Busenbender T., Hauschild J., Girich E.V., Kriegs M., Hoffer K., Graefen M., Yurchenko A.N., Bokemeyer C, & von Amsberg G. (2022). Cytotoxic N-Methylpretrichodermamide B Reveals Anticancer Activity and Inhibits P-Glycoprotein in Drug-Resistant Prostate Cancer Cells. Marine Drugs, 20(10), 597.